Zenas BioPharma, Inc.
Institutional Ownership & Holdings Analysis
About
zenas-biopharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | SR ONE CAPITAL MANAGEMENT, LP(2025-03-31) | $38.8M |
| 2 | Enavate Sciences GP, LLC(2025-03-31) | $29.7M |
| 3 | FMR LLC(2025-03-31) | $22.5M |
| 4 | NEA Management Company, LLC(2025-03-31) | $20.7M |
| 5 | Novo Holdings A/S(2025-03-31) | $17.5M |
| 6 | Fairmount Funds Management LLC(2025-03-31) | $15.0M |
| 7 | NVP Associates, LLC(2025-03-31) | $14.5M |
| 8 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)(2025-03-31) | $12.3M |
| 9 | Vivo Capital, LLC(2025-03-31) | $9.3M |
| 10 | FEDERATED HERMES, INC.(2025-03-31) | $9.1M |
| 11 | ArrowMark Colorado Holdings LLC(2025-03-31) | $8.7M |
| 12 | BlackRock, Inc.(2025-03-31) | $8.0M |
| 13 | VANGUARD GROUP INC(2025-03-31) | $7.7M |
| 14 | Rock Springs Capital Management LP(2025-03-31) | $6.9M |
| 15 | WELLINGTON MANAGEMENT GROUP LLP(2025-03-31) | $6.9M |
| 16 | PERCEPTIVE ADVISORS LLC(2024-12-31) | $6.1M |
| 17 | $5.8M | |
| 18 | PRICE T ROWE ASSOCIATES INC /MD/(2025-03-31) | $4.1M |
| 19 | Eversept Partners, LP(2025-03-31) | $3.5M |
| 20 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $2.8M |
As of 2025-03-31
Value:$38.8M
As of 2025-03-31
Value:$29.7M
#3FMR LLC
As of 2025-03-31
Value:$22.5M
As of 2025-03-31
Value:$20.7M
As of 2025-03-31
Value:$17.5M
As of 2025-03-31
Value:$15.0M
As of 2025-03-31
Value:$14.5M
As of 2025-03-31
Value:$12.3M
As of 2025-03-31
Value:$9.3M
As of 2025-03-31
Value:$9.1M
As of 2025-03-31
Value:$8.7M
As of 2025-03-31
Value:$8.0M
As of 2025-03-31
Value:$7.7M
As of 2025-03-31
Value:$6.9M
As of 2025-03-31
Value:$6.9M
As of 2024-12-31
Value:$6.1M
As of 2025-03-31
Value:$5.8M
As of 2025-03-31
Value:$4.1M
As of 2025-03-31
Value:$3.5M
As of 2025-03-31
Value:$2.8M
Total Institutional Holders:79
Top 10 Holders Own:71.3%